cvs glp-1 news Health CEO David Joyner addresses the high cost of weight loss and diabetes drugs in an interview with @jimcramer CVS steps up to help

"The most notable benefits of GLP-1 receptor agonists for patients with diabetes or obesity are their ability to promote significant weight loss, reduction in appetite, and improvement in blood sugar control," says Dr

He said Novo is confident it can sustain the strong uptake of the Wegovy pill as the program launches, touting that the pill has slightly higher efficacy and fewer drug-to-drug interactions when one medication changes how another works in the body compared with Lilly's

& Gustafson, J

Legal Disclosures Promotional value expires 360 days after purchase

Similarly, the recent FLOW trial demonstrated that semaglutide significantly reduced the risk of major kidney outcomes in patients with type 2 diabetes and CKD